[go: up one dir, main page]

AR036717A1 - Composicion combinada antioxidante y su uso - Google Patents

Composicion combinada antioxidante y su uso

Info

Publication number
AR036717A1
AR036717A1 ARP020103715A ARP020103715A AR036717A1 AR 036717 A1 AR036717 A1 AR 036717A1 AR P020103715 A ARP020103715 A AR P020103715A AR P020103715 A ARP020103715 A AR P020103715A AR 036717 A1 AR036717 A1 AR 036717A1
Authority
AR
Argentina
Prior art keywords
antioxidant composition
combined antioxidant
zwitterion
carnitine
acceptable salt
Prior art date
Application number
ARP020103715A
Other languages
English (en)
Inventor
Simone Claudio De
Original Assignee
Simone Claudio De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Simone Claudio De filed Critical Simone Claudio De
Publication of AR036717A1 publication Critical patent/AR036717A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una composición que se puede administrar en forma oral o parenteral que comprende los siguientes componentes: (a) zwitterión de L-carnitina o una sal farmacológicamente aceptable de la misma; (b) zwitterión de acetil L-carnitina o una sal farmacológicamente aceptable de la misma; (c) ácido alfa-lipoico; (d) coenzima Q10; (e) vitamina E; y (f) selenometionina, adecuada para contrarrestar el estrés oxidativo y el uso de la misma.
ARP020103715A 2001-10-03 2002-10-02 Composicion combinada antioxidante y su uso AR036717A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/968,986 US6923960B2 (en) 2001-10-03 2001-10-03 Antioxidant combination composition and use thereof

Publications (1)

Publication Number Publication Date
AR036717A1 true AR036717A1 (es) 2004-09-29

Family

ID=25515024

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020103715A AR036717A1 (es) 2001-10-03 2002-10-02 Composicion combinada antioxidante y su uso

Country Status (7)

Country Link
US (4) US6923960B2 (es)
EP (1) EP1432412A2 (es)
CN (1) CN1809344A (es)
AR (1) AR036717A1 (es)
AU (1) AU2002347614A1 (es)
CA (1) CA2457762A1 (es)
WO (1) WO2003028714A2 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020052402A1 (en) * 2000-10-31 2002-05-02 Colgate-Palmolive Company Composition and method
DE60030787T2 (de) * 2000-12-15 2007-09-13 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Verwendung von l-carnitin als stabilitsator für proteine
US20040248982A1 (en) * 2003-06-09 2004-12-09 Dyer Gordon Wayne Use of compounds for the inhibition of proteins and UV protection
US20060110477A1 (en) * 2004-11-22 2006-05-25 Mccleary Edward L Composition and method for supporting and promoting healthy sexual function and prevention and treatment of sexual dysfunction
CN102907561A (zh) * 2004-12-30 2013-02-06 希尔氏宠物营养品公司 提高老年动物的生活质量的方法
US8252742B2 (en) 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
PL1754478T3 (pl) 2005-08-04 2009-07-31 Encrypta Gmbh Ciekła kompozycja zawierająca argininę i kwas α-liponowy, oraz jej zastosowanie do poprawy sprawności seksualnej
US8367121B2 (en) * 2005-11-23 2013-02-05 Florida A & M University Nutraceutical agent for attenuating the neurodegenerative process associated with Parkinson's disease
CN101045048B (zh) * 2006-03-27 2011-05-18 中国科学院上海生命科学研究院 线粒体营养素组合物的应用
WO2008090291A1 (fr) * 2007-01-17 2008-07-31 Nbc Nutraceutic Business Consulting Composition dietetique antioxydante a base de fruits et legumes, son procede d'obtention et utilisation de la composition
KR100869444B1 (ko) * 2007-07-11 2008-11-18 주식회사 중외제약 유비데카레논을 함유하는 다층정 비타민 복합제제
WO2009020317A2 (en) * 2007-08-06 2009-02-12 Biogenics, Inc. Stabilized antioxidant particles, composition comprising the same and method for preparing the same
WO2011143104A1 (en) * 2010-05-12 2011-11-17 Hill's Pet Nutrition, Inc. Methods of control and prophylaxis of inflammation and mitigation of inflammatory conditions in companion animals
IT1406329B1 (it) * 2010-12-27 2014-02-21 Istituto Biochimico Naz Savio Composizione antiossidante per la prevenzione ed il trattamento di patologie ascrivibili al decadimento mitocondriale
RU2464816C1 (ru) * 2011-04-14 2012-10-27 Общество с ограниченной ответственностью "Вилави" Композиция биологически активных веществ, обладающая геропротекторной активностью, и способ комплексной коррекции возрастных изменений гормонального баланса, функций эпифиза и антиоксидантного статуса, включающий введение указанной композиции
US10300101B2 (en) 2012-09-19 2019-05-28 Quality IP Holdings, LLC Methods and compositions for enhancing or maintaining fertility
US9198889B2 (en) 2012-09-19 2015-12-01 Quality IP Holdings, LLC Methods for treating post-traumatic stress disorder
US8747922B2 (en) 2012-09-19 2014-06-10 Quality Ip Holdings, Inc. Methods and compositions for increasing sex steroids and growth hormones
US8747921B2 (en) 2012-09-19 2014-06-10 Quality Ip Holdings, Inc. Methods for improving health in humans
US10292957B2 (en) 2012-09-20 2019-05-21 Quality IP Holdings, LLC Compositions and methods for treating fibromyalgia
US9066953B2 (en) 2012-09-20 2015-06-30 Quality IP Holdings, LLC Methods for increasing endurance and fat metabolism in humans
US8715752B2 (en) 2012-09-20 2014-05-06 Quality Ip Holdings, Inc. Compositions for increasing human growth hormone levels
US8747923B2 (en) 2012-09-20 2014-06-10 Quality Ip Holdings, Inc. Methods for improving health in canines
US8815311B2 (en) * 2012-09-20 2014-08-26 Quality IP Holdings, LLC Methods for improving thyroid function in a subject
US9138453B2 (en) 2013-10-14 2015-09-22 Biomarker Pharmaceuticals, Inc. Nutrient combinations for affecting an aging process
US10894072B2 (en) 2017-02-13 2021-01-19 IP Quality Holdings, LLC Compositions and methods for treating fibromyalgia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292538A (en) 1992-07-22 1994-03-08 Metagenics, Inc. Improved sustained energy and anabolic composition and method of making
IT1283967B1 (it) 1996-03-29 1998-05-07 Sigma Tau Ind Farmaceuti Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi
US5976568A (en) 1997-02-21 1999-11-02 Medical Doctors' Research Institute, Inc. Modular system of dietary supplement compositions for optimizing health benefits and methods
ES2201467T3 (es) 1997-03-27 2004-03-16 Michael J. Sole Composicion nutritiva para la mejora energetica de la celula.
US5863940A (en) * 1997-12-01 1999-01-26 Sigma-Tau Healthscience S.P.A. Medicament and therapeutical method for treating idiopathic asthenozoospermia
IT1299197B1 (it) 1998-06-30 2000-02-29 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante, antiproliferativa, energetica e atta a migliorare l'utilizzazione metabolica del glucosio.
IT1302125B1 (it) 1998-08-03 2000-07-31 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante ed antiproliferativacomprendente una carnitina ed un carotenoide
IT1302307B1 (it) 1998-09-01 2000-09-05 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil
IT1302863B1 (it) 1998-11-13 2000-10-10 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante e preventiva di alterazionitrombotiche e aterosclerotiche comprendente una carnitina ed un
US6479069B1 (en) 1999-09-23 2002-11-12 Juvenon, Inc. Nutritional supplement for increased energy and stamina
US6335361B1 (en) 1999-11-03 2002-01-01 Juvenon Inc. Method of treating benign forgetfulness
US6964969B2 (en) * 2001-04-19 2005-11-15 Mccleary Edward Larry Composition and method for treating impaired or deteriorating neurological function

Also Published As

Publication number Publication date
AU2002347614A1 (en) 2003-04-14
US20050197280A1 (en) 2005-09-08
US20050186196A1 (en) 2005-08-25
EP1432412A2 (en) 2004-06-30
WO2003028714A3 (en) 2004-03-04
CA2457762A1 (en) 2003-04-10
US20030068309A1 (en) 2003-04-10
WO2003028714A2 (en) 2003-04-10
CN1809344A (zh) 2006-07-26
US6923960B2 (en) 2005-08-02
US20050118153A1 (en) 2005-06-02

Similar Documents

Publication Publication Date Title
AR036717A1 (es) Composicion combinada antioxidante y su uso
HN2002000275A (es) Derivados de 1,8 naftiridina y su uso para el tratamiento de diabetes y trastornos relacionados
HN2003000215A (es) Nuevos derivados de glicocido de tiofeno, procedimientos para la preparacion de los mismos, medicamentos que contienen estos compuestos, y el uso de los mismos.
CR7820A (es) Nuevos derivados de fluoroglicosidos heterociclicos, productos farmaceuticos que contienen dichos compuestos, y el uso de los mismos
AR058433A1 (es) Derivado de 1,1-dioxido de 1,4-benzotiazepina ,procedimiento para su preparacion ,medicamentos que comprenden este compuesto y su uso
ES2188214T3 (es) Composicion antioxidante que comprende acetil l-carnitina y acido alfa-lipoico.
ECSP034830A (es) Derivados sustituidos de la ciclohexano-1,4- diamina
PA8545301A1 (es) Nuevos derivados de quinolina
DK2311818T3 (da) Kombination af en 5-phenylthiazolforbindelse som PI3-kinasehæmmer med et antiinflammatorisk, bronchodilatorisk eller antihistaminisk medikament
AR077478A2 (es) Derivados de oxindol sustituido medicamentos que los comprenden y uso de los mismos
ECSP11011065A (es) Composición farmacéutica de un potente inhibidor de hcv para su administración oral
HN2003000183A (es) Difenilazetidinonas sustituidas en anillo procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso.
AR051405A1 (es) Compuestos de 2-carboxamido(3-amino)tiofeno
NO20033618L (no) Ftalayinon-piperidino-derivater som PDE-4-inhibitorer
PA8555401A1 (es) Derivados de quinolina
CL2007001752A1 (es) Compuesto 4-[5(2-amino-etansulfonil)-isoquinolin-7-il]-fenolo una sal farmaceuticamente aceptable o un hidrato o la sal del mismo;composicion farmaceutica que comprende a dicho compuesto,composicion farmaceutica liofilizada;y uso del compuesto como antineiplasico y/o antiviral.
ECSP10010303A (es) (dihidro)pirrolo[2,1-a]isoquinolinas
AR033325A1 (es) Composicion que comprende una carnitina y glutationa , util para incrementar la absorcion de la glutationa y sinergizar sus efectos, un complemento dietario, medicamento, la utilizacion de una composicion de combinacion para preparar un complemento dietario o un medicamento
BR0316645A (pt) Derivados de isoindol
CO6321285A2 (es) Uso de 3,11b-cis- dihidrotetrabenazina en el tratamiento de la esclerosis multiple y la mielitis autoinmunitaria
PA8531701A1 (es) Derivados de pirimidina
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
AR055099A1 (es) Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol
AR062784A1 (es) Tratmiento de los vertigos con acetil -l- leucina
DOP2002000373A (es) Composiciones que contienen imidazotriazinona para administración nasal

Legal Events

Date Code Title Description
FA Abandonment or withdrawal